CP
GILD icon

Castleview Partners’s Gilead Sciences GILD Stock Holding History

Castleview Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Buy
6,286
+1,165
+23% +$153K 0.35% 67
2026
Q1 		$714K Buy
5,121
+112
+2% +$15.7K 0.37% 63
2025
Q4 		$615K Buy
5,009
+493
+11% +$59.9K 0.3% 71
2025
Q3 		$501K Buy
4,516
+289
+7% +$32.8K 0.27% 80
2025
Q2 		$469K Buy
4,227
+513
+14% +$54.6K 0.3% 83
2025
Q1 		$416K Sell
3,714
-460
-11% -$47.5K 0.28% 94
2024
Q4 		$384K Buy
4,174
+674
+19% +$60.7K 0.21% 119
2024
Q3 		$293K Buy
3,500
+143
+4% +$10.9K 0.17% 141
2024
Q2 		$230K Buy
3,357
+899
+37% +$60K 0.13% 154
2024
Q1 		$180K Buy
2,458
+819
+50% +$63K 0.1% 189
2023
Q4 		$133K Sell
1,639
-3
-0.2% -$233 0.09% 171
2023
Q3 		$123K Buy
1,642
+19
+1% +$1.46K 0.11% 153
2023
Q2 		$125K Sell
1,623
-1,176
-42% -$93.8K 0.11% 159
2023
Q1 		$232K Buy
2,799
+113
+4% +$9.36K 0.21% 113
2022
Q4 		$231K Sell
2,686
-66
-2% -$5.23K 0.22% 104
2022
Q3 		$170K Buy
2,752
+1,052
+62% +$66.3K 0.16% 137
2022
Q2 		$24.1K Sell
1,700
-1,100
-39% -$68.1K 0.02% 372
2022
Q1 		$166K Sell
2,800
-219,386
-99% -$14M 0.1% 187
2021
Q4 		$3.06K Buy
+222,186
New +$15.3M 0.02% 226
2021
Q2 		$103K Buy
+1,496
New +$99.9K 0.05% 281

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Castleview Partners's GILD Position: Q2 2026 in Review

Castleview Partners increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $153K and bringing the position to 6,286 shares worth $794K. The position accounts for 0.35% of the portfolio, ranked #67.

Castleview Partners first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Castleview Partners held 6,286 shares of Gilead Sciences worth $794K as of Q2 2026.
  • Castleview Partners bought 1,165 Gilead Sciences shares in Q2 2026, an estimated $153K.
  • Gilead Sciences made up 0.35% of Castleview Partners's portfolio in Q2 2026, its #67 holding.
  • Castleview Partners first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.